UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000043274 |
|---|---|
| Receipt number | R000049390 |
| Scientific Title | Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use |
| Date of disclosure of the study information | 2021/02/07 |
| Last modified on | 2021/02/07 18:37:51 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use
Acronym
Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use
Scientific Title
Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use
Scientific Title:Acronym
Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use
Region
| Japan |
Condition
Condition
asthma
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
we aimed to elucidate the clinical characteristics and outcomes of severe asthma patients who used biologic drug.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Change of asthma control test after the latest biologic drug use.
Key secondary outcomes
Annual exacerbation rate, oral corticosteroid dose
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Severe asthma patients (equivalent to guideline steps 4 or 5, according 18 to the Global Initiative for Asthma 2019) who received biologic drug for the treatment of asthma
Key exclusion criteria
History of immunodeficiency or malignancy
Target sample size
105
Research contact person
Name of lead principal investigator
| 1st name | Akaba |
| Middle name | |
| Last name | Tomohiro |
Organization
Tokyo Women's Medical University
Division name
Department of respiratory medicine
Zip code
162-0054
Address
8-1, Kawada-cho, Shinjuku-ku, Tokyo
TEL
03-3353-8111
akaba.tomohiro@twmu.ac.jp
Public contact
Name of contact person
| 1st name | Akaba |
| Middle name | |
| Last name | Tomohiro |
Organization
Tokyo Women's Medical University
Division name
Department of respiratory medicine
Zip code
162-0054
Address
8-1, Kawada-cho, Shinjuku-ku, Tokyo
TEL
03-3353-8111
Homepage URL
akaba.tomohiro@twmu.ac.jp
Sponsor or person
Institute
Tokyo Women's Medical University
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tokyo women's medical university
Address
Kawada-cho 8-1, shinjuku-ku, Tokyo, Japan
Tel
03-3353-8111
rinri.b@twmu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 02 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
105
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2020 | Year | 05 | Month | 19 | Day |
Date of IRB
| 2020 | Year | 05 | Month | 19 | Day |
Anticipated trial start date
| 2020 | Year | 05 | Month | 19 | Day |
Last follow-up date
| 2020 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Observational study
Management information
Registered date
| 2021 | Year | 02 | Month | 07 | Day |
Last modified on
| 2021 | Year | 02 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049390
